在2型糖尿病中使用IdaGlar和Semaglutide联合治疗后脂质水平的稳定:一项回顾性研究
Fangfang Li1, Junmiao Li1, Jie Liu1
1Internal Medicine Department, Shunyi Maternal and Children's Hospital of Beijing Children's Hospital Beijing 101300, China.
American journal of translational research
|January 19, 2026
概括
强化治疗 degludec-aspart 双 insuline 和 semaglutide 改善了 2 型糖尿病患者的血糖控制和脂质水平. 这种组合疗法增强了胰岛素功能,但没有增加不良反应.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 管理需要有效的策略来控制高血糖和代谢参数.
- 越来越多地探索组合疗法,以实现T2DM患者的最佳血糖和脂质控制.
研究的目的:
- 评估在T2DM患者中使用德格卢德克-阿斯帕特双胰岛素与西马格卢丁结合的强化治疗对脂质代谢的临床疗效和影响.
- 为了比较这种组合治疗与对照组对各种代谢指标的影响.
主要方法:
- 进行了糖脂代谢指标,血糖波动指标,胰岛素功能标志物,胰岛素耐药性,内脏脂肪指数和脂质资料的系统比较.
- 统计分析包括了与基线的变化和治疗组和对照组之间的不良反应发生率.
主要成果:
- 与基线相比,这两组治疗组在治疗后的代谢指标均有所改善.
- 接受德格卢德克-阿斯帕特双胰岛素加西马格卢提德的组在血糖控制,胰岛素功能和脂质配置文件 (P <0.05) 中表现出明显优异的改善.
- 两组之间没有观察到不良反应发生率的显著差异 (P=0.576).
结论:
- 强化治疗 degludec-aspart 双 insuline 和 semaglutide 是有效的改善 T2DM 的血糖控制.
- 这种组合疗法对胰岛素功能产生积极影响,并有助于稳定脂质水平.
- 治疗方案被发现是安全的,与对照组相比,没有增加不良反应的风险.
相关概念视频
03:17Static Strength Training Method for Type 2 Diabetic Mice
975
This protocol provides a simple method of making static training equipment for mice. The device maintains the muscle isometric contraction of the limbs of mice so as to verify the intervention effect of traditional exercise on type 2 diabetes (T2DM) and provides new exercise therapy for the clinical treatment of...
975
01:22Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
6.2K
6.2K
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
3.2K
In line with the urgent need for screening for type 1 diabetes, celiac disease, and coronavirus disease 2019, we developed a high throughput 6-Plex electrochemiluminescence assay to simultaneously detect all four islet autoantibodies, tissue transglutaminase autoantibodies, and antibodies to the receptor binding domain of severe acute respiratory syndrome coronavirus...
3.2K
07:00Using Caco-2 Cells to Study Lipid Transport by the Intestine
19.7K
Caco-2 cells can serve as an in vitro model to study the enterocyte transport of lipids, and lipid-soluble drugs/vitamins. The permeable membrane system separates the apical from the basolateral compartment, while the lentivirus expression system offers an effective gene overexpression method. The isolation of lipoproteins is confirmed by...
19.7K
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
7.4K
A simple and reliable diet-induced rodent animal model for nonalcoholic steatohepatitis (NASH) is described, achieved through non-SPF housing of the animals and administration of a specific high-fat diet. We describe identification of hepatic and adipose immune cell subsets to recapitulate human immunological conditions by exposing mice to environmental...
7.4K